In our hands, O-GlcNAcylation does not seem to affect either stability or catalytic activity of EZH2 but appears to regulate the binding of EZH2 at specific loci including the UNC5A promoter in colon cancer cells. Here, UNC5A is linked to malignant colon neoplasm.